CytomX Therapeutics, Inc.
US ˙ NasdaqGS ˙ US23284F1057

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de McCarthy Sean A.. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que McCarthy Sean A. reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:CTMX / CytomX Therapeutics, Inc. CEO, Director 1,078,922
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por McCarthy Sean A.. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas CTMX / CytomX Therapeutics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em CTMX / CytomX Therapeutics, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

CTMX / CytomX Therapeutics, Inc. Insider Trades
Vendas Internas CTMX / CytomX Therapeutics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em CTMX / CytomX Therapeutics, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2026-03-17 CTMX McCarthy Sean A. 118,969 6.4230 118,969 6.4230 764,138 77 3.1600 -388,195 -50.80
2025-06-16 CTMX McCarthy Sean A. 55,511 2.6889 55,511 2.6889 149,264
2025-03-18 CTMX McCarthy Sean A. 37,656 0.5990 37,656 0.5990 22,556
2024-08-20 CTMX McCarthy Sean A. 13,898 1.2291 13,898 1.2291 17,082
2024-03-19 CTMX McCarthy Sean A. 20,223 2.0855 20,223 2.0855 42,175
2023-12-20 CTMX McCarthy Sean A. 13,551 1.3807 13,551 1.3807 18,710
2023-09-22 CTMX McCarthy Sean A. 14,601 1.3004 14,601 1.3004 18,987
2023-03-16 CTMX McCarthy Sean A. 7,121 1.8805 7,121 1.8805 13,391
2022-07-20 CTMX McCarthy Sean A. 14,911 1.4222 14,911 1.4222 21,206
2017-09-01 CTMX McCarthy Sean A. 368 17.5000 368 17.5000 6,440
2017-08-31 CTMX McCarthy Sean A. 9,194 17.5000 9,194 17.5000 160,895

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

CTMX / CytomX Therapeutics, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por McCarthy Sean A. conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-03-19 2026-03-17 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -118,969 1,078,922 -9.93 6.42 -764,138 6,929,916
2026-02-04 2026-02-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 210,000 1,197,891 21.26
2025-11-10 2025-11-06 4 CTMX CytomX Therapeutics, Inc.
Class A Common Stock
S - Sale X -101,793 987,891 -9.34 4.54 -461,906 4,482,753
2025-06-17 2025-06-16 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -55,511 1,089,684 -4.85 2.69 -149,264 2,930,051
2025-06-17 2025-06-13 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 150,000 1,145,195 15.07
2025-03-20 2025-03-18 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -37,656 995,195 -3.65 0.60 -22,556 596,122
2025-02-06 2025-02-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 195,000 1,032,851 23.27
2025-02-06 2025-02-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 180,000 837,851 27.36
2024-08-22 2024-08-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -13,898 657,851 -2.07 1.23 -17,082 808,565
2024-08-22 2024-08-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 37,500 671,749 5.91
2024-03-28 2024-03-26 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 109,768 634,249 20.93 1.57 172,874 998,879
2024-03-21 2024-03-19 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -20,223 524,481 -3.71 2.09 -42,175 1,093,805
2024-01-19 2024-01-18 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 90,000 544,704 19.79
2023-12-22 2023-12-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -13,551 454,704 -2.89 1.38 -18,710 627,810
2023-12-19 2023-12-17 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 37,500 468,255 8.71
2023-09-22 2023-09-22 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -14,601 430,755 -3.28 1.30 -18,987 560,154
2023-09-22 2023-09-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 40,000 445,356 9.87
2023-05-23 2023-05-19 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 16,535 405,356 4.25 1.57 26,041 638,395
2023-03-20 2023-03-16 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -7,121 388,821 -1.80 1.88 -13,391 731,178
2023-02-06 2023-02-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 105,000 395,942 36.09
2022-07-21 2022-07-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -14,911 290,942 -4.88 1.42 -21,206 413,778
2022-07-21 2022-07-19 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 40,000 305,853 15.05
2022-05-11 2022-05-09 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -24,189 0 -100.00
2022-05-11 2022-05-09 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -66,742 0 -100.00
2022-05-11 2022-05-09 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 24,189 265,853 10.01 0.94 22,859 251,231
2022-05-11 2022-05-09 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 66,742 241,664 38.16 0.94 63,071 228,372
2022-02-04 2022-02-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 450,000 450,000
2022-02-04 2022-02-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 75,000 174,922 75.06
2021-10-26 2021-10-24 4 CTMX CytomX Therapeutics, Inc.
Performance Stock Units (PSUs)
A - Award 80,000 80,000
2021-10-26 2021-10-24 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 100,000 100,000
2021-08-13 2021-08-11 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -92,113 0 -100.00
2021-08-13 2021-08-11 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 92,113 99,922 1,179.57 1.13 104,447 113,302
2021-06-21 2021-06-16 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -100,000 93,118 -51.78 7.04 -704,470 655,988
2021-06-16 2021-06-14 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -10 66,742 -0.01
2021-06-16 2021-06-14 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -30 92,113 -0.03
2021-06-16 2021-06-14 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 10 7,849 0.13 0.94 9 7,417
2021-06-16 2021-06-14 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 30 7,839 0.38 1.13 34 8,889
2021-06-08 2019-09-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
G - Gift -4,500 7,809 -36.56
2021-04-02 2021-03-31 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -100,000 92,143 -52.04
2021-04-02 2021-03-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -100,000 206,894 -32.58 7.49 -749,470 1,550,608
2021-04-02 2021-03-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 100,000 306,894 48.33 1.13 113,390 347,987
2021-03-02 2021-02-27 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 200,000 200,000
2021-03-02 2021-02-26 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 400,000 400,000
2020-12-28 2020-12-23 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -100,000 192,143 -34.23
2020-12-28 2020-12-23 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 100,000 206,894 93.55 1.13 113,390 234,597
2020-12-07 2020-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 930 106,894 0.88 6.39 5,945 683,266
2020-09-23 2020-09-21 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -20,500 0 -100.00
2020-09-23 2020-09-21 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 20,500 105,964 23.99 6.61 135,601 700,920
2020-06-02 2020-05-29 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 1,158 85,464 1.37 5.11 5,916 436,593
2020-05-14 2020-05-12 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -36,000 292,143 -10.97
2020-05-14 2020-05-12 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -36,000 84,306 -29.92 15.00 -540,000 1,264,590
2020-05-14 2020-05-12 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 36,000 120,306 42.70 1.13 40,820 136,415
2020-02-19 2020-02-14 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 500,000 500,000
2019-12-16 2019-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 1,080 84,306 1.30 5.32 5,747 448,592
2019-06-04 2019-05-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 695 83,226 0.84 8.21 5,707 683,369
2019-01-29 2019-01-25 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 300,000 300,000
2018-12-06 2018-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 468 82,531 0.57 11.73 5,490 968,089
2018-11-05 2018-11-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -1,156 136,071 -0.84
2018-11-05 2018-11-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -1,156 82,063 -1.39 15.01 -17,348 1,231,519
2018-11-05 2018-11-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 1,156 83,219 1.41 1.57 1,821 131,062
2018-11-05 2018-11-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -5,370 137,227 -3.77
2018-11-05 2018-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -5,270 82,063 -6.03 15.00 -79,050 1,230,945
2018-11-05 2018-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -100 87,333 -0.11 15.00 -1,500 1,310,432
2018-11-05 2018-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 5,370 87,433 6.54 1.57 8,457 137,698
2018-09-06 2018-09-04 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X 13,052 142,597 10.08
2018-09-06 2018-09-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -13,052 82,063 -13.72 21.86 -285,343 1,794,061
2018-09-06 2018-09-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 13,052 95,115 15.90 1.57 20,556 149,797
2018-07-09 2018-07-05 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -4,497 155,649 -2.81
2018-07-09 2018-07-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4,497 82,063 -5.20 25.06 -112,689 2,056,384
2018-07-09 2018-07-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 4,497 86,560 5.48 1.57 7,082 136,323
2018-07-06 2018-07-03 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -2,028 160,146 -1.25
2018-07-06 2018-07-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -2,028 82,063 -2.41 25.09 -50,880 2,058,879
2018-07-06 2018-07-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 2,028 84,091 2.47 1.57 3,194 132,435
2018-07-03 2018-07-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -13,052 162,174 -7.45
2018-07-03 2018-07-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -13,052 82,063 -13.72 23.42 -305,708 1,922,104
2018-07-03 2018-07-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 13,052 95,115 15.90 1.57 20,556 149,797
2018-06-05 2018-05-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 302 4,945 6.50 17.90 5,406 88,520
2018-05-02 2018-05-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise X -19,578 175,226 -10.05
2018-05-02 2018-05-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -19,578 4,643 -80.83 26.55 -519,743 123,259
2018-05-02 2018-05-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise X 19,578 24,221 421.67 1.57 30,833 38,146
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -62 66,752 -0.09
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -9,000 328,143 -2.67
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -10,516 194,804 -5.12
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -19,578 4,643 -80.83 29.43 -576,141 136,634
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 62 24,221 0.26 0.94 59 22,889
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 9,000 24,159 59.37 1.13 10,205 27,394
2018-03-05 2018-03-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 10,516 15,159 226.49 1.57 16,562 23,874
2018-02-12 2017-09-07 5 CTMX CytomX Therapeutics, Inc.
Common Stock
G - Gift -4,500 154,237 -2.83
2018-01-26 2018-01-24 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 300,000 300,000
2018-01-09 2018-01-05 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -6,526 337,143 -1.90
2018-01-09 2018-01-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -6,526 4,643 -58.43 25.01 -163,215 116,121
2018-01-09 2018-01-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 6,526 11,169 140.56 1.13 7,400 12,665
2018-01-04 2018-01-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -13,052 343,669 -3.66
2018-01-04 2018-01-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -13,052 4,643 -73.76 21.04 -274,614 97,689
2018-01-04 2018-01-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 13,052 17,695 281.11 1.13 14,800 20,064
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -10,240 356,721 -2.79
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4,100 115,193 -3.44
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -14,340 4,643 -75.54 20.60 -295,404 95,646
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 10,240 18,983 117.12 1.13 11,611 21,525
2017-12-05 2017-12-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4,100 8,743 88.30 0.94 3,874 8,262
2017-12-05 2017-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 398 4,643 9.38 12.15 4,834 56,396
2017-11-03 2017-11-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -14,342 119,293 -10.73
2017-11-03 2017-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -14,342 4,245 -77.16 19.86 -284,832 84,306
2017-11-03 2017-11-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 14,342 18,587 337.86 0.94 13,553 17,565
2017-10-06 2017-10-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise -19,120 133,635 -12.52
2017-10-06 2017-10-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -19,120 4,245 -81.83 24.13 -461,366 102,432
2017-10-06 2017-10-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 19,120 23,365 450.41 0.94 18,068 22,080
2017-10-04 2017-10-02 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -9,562 15,481 -38.18
2017-10-04 2017-10-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -9,562 4,245 -69.25 18.57 -177,566 78,830
2017-10-04 2017-10-02 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 9,562 13,807 225.25 0.94 9,036 13,048
2017-09-22 2017-09-01 4/A CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -9,930 25,043 -28.39
2017-09-22 2017-09-01 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -368 4,245 -7.98 17.50 -6,440 74,288
2017-09-22 2017-09-01 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -9,562 4,613 -67.46 17.32 -165,614 79,897
2017-09-22 2017-09-01 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 9,930 14,175 233.92 0.94 9,384 13,395
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -18,756 34,973 -34.91
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale -9,194 4,245 -68.41 17.50 -160,895 74,288
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -3,000 13,439 -18.25 17.51 -52,530 235,317
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -6,562 16,439 -28.53 17.50 -114,835 287,682
2017-09-22 2017-08-31 4/A CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 18,756 23,001 441.84 0.94 17,724 21,736
2017-09-05 2017-09-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -9,930 25,043 -28.39
2017-09-05 2017-09-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -9,930 4,245 -70.05 17.32 -171,988 73,523
2017-09-05 2017-09-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 9,930 14,175 233.92 0.94 9,384 13,395
2017-09-01 2017-08-31 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -18,756 34,973 -34.91
2017-09-01 2017-08-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -3,000 4,245 -41.41 17.51 -52,530 74,330
2017-09-01 2017-08-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -15,756 7,245 -68.50 17.50 -275,730 126,788
2017-09-01 2017-08-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 18,756 23,001 441.84 0.94 17,724 21,736
2017-08-11 2017-08-09 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4,781 53,729 -8.17
2017-08-11 2017-08-09 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4,781 4,245 -52.97 15.00 -71,715 63,675
2017-08-11 2017-08-09 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4,781 9,026 112.63 0.94 4,518 8,530
2017-07-06 2017-07-03 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4,781 58,510 -7.55
2017-07-06 2017-07-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4,781 4,245 -52.97 15.52 -74,201 65,882
2017-07-06 2017-07-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4,781 9,026 112.63 0.94 4,518 8,530
2017-06-27 2017-06-26 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4,481 63,291 -6.61
2017-06-27 2017-06-26 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X 4,481 4,245 -1,898.73 15.00 67,215 63,675
2017-06-27 2017-06-26 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4,481 8,726 105.56 0.94 4,235 8,246
2017-06-06 2017-06-05 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -300 67,772 -0.44
2017-06-06 2017-06-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -300 4,245 -6.60 15.00 -4,500 63,675
2017-06-06 2017-06-05 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 300 4,545 7.07 0.94 284 4,295
2017-06-02 2017-05-31 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 2,266 4,245 114.50 8.68 19,665 36,840
2017-05-02 2017-05-01 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4,781 68,072 -6.56
2017-05-02 2017-05-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4,781 1,979 -70.72 15.70 -75,062 31,070
2017-05-02 2017-05-01 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4,781 6,760 241.59 0.94 4,518 6,388
2017-04-05 2017-04-04 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4,781 72,853 -6.16
2017-04-05 2017-04-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4,781 1,979 -70.72 17.50 -83,668 34,632
2017-04-05 2017-04-04 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4,781 6,760 241.59 0.94 4,518 6,388
2017-04-05 2017-04-03 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -4,781 77,634 -5.80
2017-04-05 2017-04-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -4,781 1,979 -70.72 16.94 -80,990 33,524
2017-04-05 2017-04-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 4,781 6,760 241.59 0.94 4,518 6,388
2017-03-21 2017-03-20 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -14,343 82,415 -14.82
2017-03-21 2017-03-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -14,343 1,979 -87.88 19.60 -281,123 38,788
2017-03-21 2017-03-20 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 14,343 16,322 724.76 0.94 13,554 15,424
2017-03-03 2017-03-03 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -14,343 366,961 -3.76
2017-03-03 2017-03-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
S - Sale X -14,343 1,979 -87.88 15.00 -215,145 29,685
2017-03-03 2017-03-03 4 CTMX CytomX Therapeutics, Inc.
Common Stock
M - Exercise 14,343 16,322 724.76 1.13 16,264 18,508
2017-01-27 2017-01-25 4 CTMX CytomX Therapeutics, Inc.
Stock Option (right to buy)
A - Award 310,000 310,000
2016-12-01 2016-11-30 4 CTMX CytomX Therapeutics, Inc.
Common Stock
A - Award 1,979 1,979 9.10 17,999 17,999
2016-09-28 2016-09-26 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 122,424 122,424
2016-09-28 2016-09-26 4 CTMX CytomX Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 48,379 48,379
2016-01-25 2016-01-21 4 CTMX CytomX Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 225,000 225,000
2015-10-07 3 CTMX CytomX Therapeutics, Inc.
Common Stock
317,474
2015-10-07 3 CTMX CytomX Therapeutics, Inc.
Common Stock
317,474
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)